The Biotech Growth Trust PLC (LON:BIOG) Insider Acquires £10,272 in Stock

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie bought 1,200 shares of the company’s stock in a transaction on Thursday, December 19th. The stock was bought at an average cost of GBX 856 ($10.70) per share, for a total transaction of £10,272 ($12,838.40).

Hamish Baillie also recently made the following trade(s):

• On Wednesday, November 27th, Hamish Baillie bought 3,000 shares of The Biotech Growth Trust stock. The shares were purchased at an average cost of GBX 931 ($11.64) per share, for a total transaction of £27,930 ($34,908.14).

The Biotech Growth Trust Stock Down 1.1 %

LON BIOG opened at GBX 853.54 ($10.67) on Friday. The company has a market capitalization of £274.24 million, a P/E ratio of 412.34 and a beta of 0.50. The Biotech Growth Trust PLC has a 12 month low of GBX 840.94 ($10.51) and a 12 month high of GBX 1,068.36 ($13.35). The company’s 50 day simple moving average is GBX 973.28 and its 200 day simple moving average is GBX 995.47. The company has a debt-to-equity ratio of 13.03, a current ratio of 0.33 and a quick ratio of 0.00.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.